This real-world NGS study identifies STAS as a key prognostic factor in lung cancer outcomes, suggesting new treatment considerations.
No takes yet. Share an insight, caveat, or question.
Elbaile et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: